Louis DN, Perry A, Burger P (2014) International Society of neuropathology–Haarlem Consensus guidelines for Nervous System Tumor classification and grading. Brain Pathol 24:429–435

Article  PubMed  PubMed Central  Google Scholar 

Louis DN, Ohgaki H, Wiestler OD (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109

Article  PubMed  PubMed Central  Google Scholar 

Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS (2020) CBTRUS Statistical Report: primary brain and other Central Nervous System tumors diagnosed in the United States in 2013–2017. Neuro-Oncol 22:1–96. https://doi.org/10.1093/neuonc/noaa200

Article  Google Scholar 

Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, Barnholtz-Sloan JS (2019) CBTRUS Statistical Report: primary brain and other Central Nervous System tumors diagnosed in the United States in 2012–2016. Neuro-Oncol 21:1–100. https://doi.org/10.1093/neuonc/noz150

Article  Google Scholar 

Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G et al (2021) The 2021 WHO classification of tumors of the Central Nervous System: a Summary. Neuro-Oncol 23:1231–1251. https://doi.org/10.1093/neuonc/noab106

Article  PubMed  PubMed Central  CAS  Google Scholar 

Taphoorn MJB, Sizoo EM, Bottomley A (2010) Review on quality of Life issues in patients with primary brain tumors. Oncologist 15:618–626. https://doi.org/10.1634/theoncologist.2009-0291

Article  PubMed  PubMed Central  Google Scholar 

Boele FW, Klein M, Reijneveld JC, Verdonck-de Leeuw IM, Heimans JJ (2014) Symptom Management and Quality of Life in Glioma patients. CNS Oncol 3:37–47. https://doi.org/10.2217/cns.13.65

Article  PubMed  PubMed Central  CAS  Google Scholar 

Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U et al (2005) Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma. N Engl J Med 352:987–996. https://doi.org/10.1056/NEJMoa043330

Article  PubMed  CAS  Google Scholar 

Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJB, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K et al (2009) Effects of Radiotherapy with Concomitant and Adjuvant Temozolomide versus Radiotherapy alone on Survival in Glioblastoma in a Randomised Phase III Study: 5-Year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–466. https://doi.org/10.1016/S1470-2045(09)70025-7

Article  PubMed  CAS  Google Scholar 

Prust M (2015) Standard chemoradiation for Glioblastoma Results in Progressive Brain volume loss. Harvard University

Petr J, Platzek I, Hofheinz F (2018) Photon vs. Proton Radiochemotherapy: effects on Brain tissue volume and perfusion. Radiother Oncol 128:121–127

Article  PubMed  Google Scholar 

Rauch PJ, Park HS, Knisely JPS, Chiang VL, Vortmeyer AO (2012) Delayed Radiation-Induced Vasculitic Leukoencephalopathy. Int J Radiat Oncol 83:369–375

Article  Google Scholar 

Terziev R, Psimaras D, Marie Y, Feuvret L, Berzero G, Jacob J, Dehais C, Bompaire F, Mueller W, Kinnersley B et al (2021) Cumulative incidence and risk factors for radiation induced leukoencephalopathy in high grade glioma long term survivors. Sci Rep 11:10176. https://doi.org/10.1038/s41598-021-89216-1

Article  PubMed  PubMed Central  CAS  Google Scholar 

Winter SF, Klein JP, Vaios EJ (2021) Clinical presentation and management of SMART Syndrome. Neurology 97:118–120

Article  PubMed  Google Scholar 

Aizer AA, Du R, Wen PY, Arvold ND (2015) Radiotherapy and Death from Cerebrovascular Disease in patients with primary brain tumors. J Neurooncol 124:291–297

Article  PubMed  CAS  Google Scholar 

Roongpiboonsopit D, Kuijf HJ, Charidimou A (2017) Evolution of cerebral microbleeds after Cranial Irradiation in Medulloblastoma patients. Neurology 88:789–796

Article  PubMed  PubMed Central  Google Scholar 

Winter SF, Loebel F, Loeffler J (2019) Treatment-induced brain tissue necrosis: a clinical challenge in neuro-oncology. Neuro Oncol 21

Verma N, Cowperthwaite MC, Burnett MG, Markey MK (2013) Differentiating Tumor recurrence from treatment necrosis: a review of Neuro-oncologic imaging strategies. Neuro Oncol 15:515–534

Article  PubMed  PubMed Central  Google Scholar 

Winter SF, Vaios EJ, Muzikansky A, Martinez-Lage M, Bussière MR, Shih HA, Loeffler J, Karschnia P, Loebel F, Vajkoczy P et al (2020) Defining treatment-related adverse effects in patients with glioma: distinctive features of Pseudoprogression and Treatment-Induced necrosis. Oncologist 25:e1221–e1232. https://doi.org/10.1634/theoncologist.2020-0085

Article  PubMed  PubMed Central  CAS  Google Scholar 

Prust MJ, Jafari-Khouzani K, Kalpathy-Cramer J, Polaskova P, Batchelor TT, Gerstner ER, Dietrich J (2015) Standard chemoradiation for Glioblastoma Results in Progressive Brain volume loss. Neurology 85:683–691. https://doi.org/10.1212/WNL.0000000000001861

Article  PubMed  PubMed Central  CAS  Google Scholar 

Prust ML, Jafari-Khouzani K, Kalpathy-Cramer J (2018) Standard chemoradiation in combination with VEGF targeted therapy for Glioblastoma Results in Progressive Gray and White Matter volume loss. Neuro Oncol 20:289–291

Article  PubMed  PubMed Central  CAS  Google Scholar 

Akintola O, Dietrich J, Muzikansky A, Melissa G, Youssef G, Huang R, Gerstner E, Wen PY, Parsons M, Gilbert M et al (2022) NCOG-20. Brain atrophy in glioblastoma patients following treatment with chemoradiation or chemoradiation with anti-angiogenic therapy in NRG/RTOG 0825 participants. Neuro-Oncol 24:vii201. https://doi.org/10.1093/neuonc/noac209.773

Article  PubMed Central  Google Scholar 

Dietrich J, Monje M, Wefel J, Meyers C (2008) Clinical patterns and Biological correlates of Cognitive Dysfunction Associated with Cancer Therapy. Oncologist 13:1285–1295. https://doi.org/10.1634/theoncologist.2008-0130

Article  PubMed  Google Scholar 

Stone JB, DeAngelis LM (2016) Cancer-Treatment-Induced neurotoxicity–focus on newer treatments. Nat Rev Clin Oncol 13:92–105. https://doi.org/10.1038/nrclinonc.2015.152

Article  PubMed  CAS  Google Scholar 

Taphoorn MJ, Klein M (2004) Cognitive deficits in adult patients with brain tumours. Lancet Neurol 3:159–168. https://doi.org/10.1016/S1474-4422(04)00680-5

Article  PubMed  Google Scholar 

Wilke C, Grosshans D, Duman J, Brown P, Li J (2018) Radiation-Induced Cognitive toxicity: pathophysiology and interventions to reduce toxicity in adults. Neuro Oncol 20:597–607

Article  PubMed  CAS  Google Scholar 

Kaiser J, Bledowski C, Dietrich J (2014) Neural correlates of Chemotherapy-related cognitive impairment. Cortex 54. https://doi.org/10.1016/j.cortex.2014.01.010

Armstrong C, Ruffer J, Corn B, DeVries K, Mollman J (1995) Biphasic patterns of memory deficits following moderate-dose partial-brain irradiation: neuropsychologic outcome and proposed mechanisms. J Clin Oncol 13(9):2263–2271. https://doi.org/10.1200/JCO.1995.13.9.2263

Article  PubMed  CAS  Google Scholar 

Butler JM, Rapp S (2006) Managing the Cognitive effects of Brain Tumor Radiation Therapy. Curr Treat Options Oncol. https://doi.org/10.1007/s11864-006-0026-5

Article  PubMed  Google Scholar 

Surma-aho O, Niemelä M, Vilkki J, Kouri M, Brander A, Salonen O, Paetau A, Kallio M, Pyykkönen J, Jääskeläinen J (2001) Adverse Long-Term effects of Brain Radiotherapy in Adult Low-Grade Glioma patients. Neurology 56:1285–1290. https://doi.org/10.1212/wnl.56.10.1285

Article  PubMed  CAS  Google Scholar 

Klein M, Heimans JJ, Aaronson NK, van der Ploeg HM, Grit J, Muller M, Postma TJ, Mooij JJ, Boerman RH, Beute GN et al (2002) Effect of Radiotherapy and Other Treatment-related factors on Mid-term to Long-Term Cognitive Sequelae in Low-Grade gliomas: a comparative study. Lancet Lond Engl 360:1361–1368. https://doi.org/10.1016/s0140-6736(02)11398-5

Article  CAS  Google Scholar 

Douw L, Klein M, Fagel SS, van den Heuvel J, Taphoorn MJ, Aaronson NK, Postma TJ, Vandertop WP, Mooij JJ, Boerman RH et al (2009) Cognitive and Radiological effects of Radiotherapy in patients with low-Grade Glioma: Long-Term Follow-Up. Lancet Neurol 8:810–818.